One decision left — made fully visible.

Executive summary

We listened to Spanish women's daily-nutrition conversation at scale, read all three analysis layers (the quantified skeleton, the verbatim language, the full threads), and most of the product is now settled by evidence. One thing is not, and it is the thing that decides everything downstream: which cohort the first SKU is for. This report lays that fork out in full so the three of you can choose it deliberately.

01Method & corpus

A proven listening pipeline (built on the GLP-1 category) re-pointed at CORA: scrape four platforms, triage every item for concern / journey-phase / emotion / life-stage / geography, store an immutable, re-queryable corpus. We optimised for a durable need, not the fastest riser — a deliberate founder decision. Corpus: 24,450 raw, 13,025 triaged. Spain is the launch market, so we held a pre-registered 25% ES-share gate, missed it (23.4%), ran a surgical Spanish top-up, and cleared it honestly to 36.3%. We then read all three layers — including the actual verbatims — which is what produced this v2.

02The concern landscape (Spain)

Ranked by the durability composite we agreed to use (size × emotion × buying-moment). Note the headline: on the metric we chose, creatine is #1 in Spain — not stress, despite stress's higher volume and emotion. Creatine wins purely on buying-intent.

*Perimenopause is inflated — see §06. A note on velocity: we are not trusting the growth slopes. The corpus's non-TikTok sources only switched on in June 2025, so 18-month "trends" mostly measure sources turning on, and the recent peri/menopause surge is partly our own Spanish anchor top-up landing in recent months. Dan's external search cross-check is the only clean growth signal — see §10.

03Buyable vs. ventable — the decisive cut

Share of mentions at a buying moment (seeking / comparing / using) versus venting. This separates a product from a feeling.

This is the spine. Creatine is what women shop for; stress is what they feel. A concern people vent about is powerful to speak to but hard to sell — especially stress, where the obvious ingredient (ashwagandha) is excluded by CORA's rules and "calm" is the most commoditised lane in the category. But the buyable ratio alone overstates the case — the language underneath it (§04) changes how you read it.

04What the language revealed

Reading the actual verbatims corrected three things the numbers alone would have led us to overstate.

Creatine demand is real but anxious — reassurance-led, not confident

The 171 "seeking" creatine mentions are overwhelmingly safety questions, not brand comparison. Women want it and are afraid of it:

"¿se puede tomar en café caliente?" · "¿no engorda, no hincha?" · "puedo tomar creatina" [with metformin / breastfeeding / a kidney stone] · "me empezó a dejar calva"

The creators answer the fear head-on ("NO ENGORDA. NO HINCHA."). Implication: the hero job is removing fear — clean, women-formulated, won't bloat, safe, drinkable in coffee — not selling strength. And note the literal product opening: women are already asking whether creatine survives in hot coffee.

Stress is thinner and more fraught than 402 implies

A real share is clinical-grade distress (years on benzodiazepines, "una depresión muy fuerte," panic) that a coffee must never position against; another share is "cortisol" creator marketing. The genuine everyday-overwhelm middle — the wrapper register — is real and vivid:

"no puedo con mi alma" · "no llego a todo" · "de aquí acabamos locas perdidas"

This confirms stress-as-wrapper and adds a tone rule: speak to everyday overwhelm, never to clinical anxiety.

Brain fog is the through-line; "claridad mental" is the prize

"Niebla mental," "ruido mental," "mente desafinada" recur, and the benefit women name for what creatine gives them is claridad mental. It connects the substance (creatine) to the emotion (stress/energy). The single sharpest articulation of the whole product may be the morning that gives you back your clarity and calm.

An acquisition opening: "no sé por dónde empezar"

Repeatedly, overwhelmed women ask for one place to start ("Tengo 43 años y no tomo ningún suplemento, no sé por dónde empezar"). That favours a single, simple, trustworthy SKU over a stack — and reinforces §05.

05One product, or a range?

06What's settled (so the decision is clean)

• Creatine is the buyable substance — #1 on the composite, organic at the anchor level (2.9%), the most purchase-intent concern. The deck's creatine removal was based on a false "gym-bro" premise and should be reversed. But its demand is reassurance-led (§04).
• Stress is the emotional wrapper, not a hero — largest and hottest, but mostly venting, partly clinical, partly creator-noise. Speak to it; don't build a SKU on it.
• Brain fog / clarity is the through-line benefit — the bridge between substance and emotion.
• Single SKU, not a range — the cluster doesn't hold.
• Perimenopause is discounted — 30.4% anchor artifact, creator-led in the verbatims, and 40+.
• Hair loss is whitespace and a creatine fear — surfaced as an unmet need and a creatine objection ("me empezó a dejar calva") to preempt. A candidate fast-follow.

07The open decision — cohort × format

This is the one fork the data sharpens but does not resolve, because it's a strategy choice, not a fact. Three signals point three ways:

• The substance (creatine) is, in Spanish, overwhelmingly a 40+ / menopause conversation — the voices are 47, 52, 65, even 87; sub-40 creatine was only n=16.
• The format (coffee) is something the 40+ cohort is actively leaving — "el café lo tomo descafeinado," "café no tomo," switching to matcha "sin tembladera y sin ese bajón horrible" because it worsens hot flashes and anxiety.
• The channel (Rafa) reaches sub-40 cheaply through studio/community.

v1 quietly assumed these aligned. They don't. Choosing the cohort resolves format, positioning and channel in one move. The three coherent paths:

The questions that actually decide it

Rather than a verdict, the levers — answer these and the option falls out:

1. Is Rafa's sub-40 access a repeatable acquisition engine, or a one-time warm list? If it's a real engine, A's smaller TAM is de-risked. If not, A loses its main advantage.
2. What CAC can we afford? The sub-40 ES core was low-spend; B's 40+ demand is more monetisable but reached via paid, not Rafa.
3. Do we want coherence or size? A is smaller but every axis aligns; B is bigger but fights its own format and channel.
4. Is creatine-in-coffee a real, ownable wedge? Women are asking the question organically; if the lab can make it taste right, that wedge favours A/coffee.
5. How much does the brand essence matter day one? CORA's identity (active, anti-pinkwash, sub-40-reachable) sits more naturally in A; B drifts toward a menopause brand.

08Formula logic

Reinstate the deck's Option 4 with creatine, and lock the serving size first (the deck's listed doses didn't reconcile with its scoop label — a bigger COGS lever than creatine). Spine: hydrolysed marine collagen + EAA blend (the complete-protein move) + Creapure creatine + MCT + L-theanine + active B-complex + D3/K2 + electrolytes; no artificial sweeteners; no ashwagandha (CORA rule), no apigenin (EU novel food).

The reassurance imperative. Because demand is fear-led, the formula must visibly answer the fears: a women's-appropriate creatine dose, an explicit no-bloat / no-water-retention story, and a clear "drinkable in hot coffee" claim. Hair-loss anxiety should be preempted, not ignored.

Sayable claims. The complete-protein claim and authorised "reduces tiredness and fatigue" claims (B6, B12, folate, magnesium, iron) are clean. The only authorised creatine claim is the high-intensity-exercise one (the gym register we're avoiding), so creatine carries the product, not the on-pack claim. Magnesium gives the authorised "normal nervous system" toehold for the calm wrapper; L-theanine drives felt calm but isn't a claimable line. VAT: Spanish food supplements registered as complementos alimenticios are 10%, not 21% — conditional on Dan's registration.

09Positioning & language

Built from the real Spanish in the corpus, not invented. Lead with the feeling, prove with the substance, reassure throughout.

The hero benefit

"Tu mañana con claridad y calma" — the morning that gives you back your clarity and energy without the jitter or the crash. Creatine + protein are the credibility underneath.

Real phrases to build from

Overwhelm (wrapper): no llego a todo · no puedo con mi alma · ruido mental. Clarity (hero): claridad mental · niebla mental fuera · energía sin nervios. Reassurance (creatine): no engorda, no hincha · creatina de verdad para mujeres · en tu café.

Don't say

Gym/performance framing; clinical or anti-anxiety promises (the tone rule); "perimenopause" as the lead (off-cohort, artifact-inflated) — unless Option B is chosen, which reframes this section entirely.

10Risks & caveats

• The category is creator/seller-saturated. Beyond our 5 anchors, the Spanish creatine and cortisol conversation is thick with other sellers (MLMs, clinics, "comenta CORTISOL" funnels). Real consumer demand exists but sits inside heavy marketing — read signal accordingly.
• Open external gate — creatine velocity. The slope data is untrustworthy (sources turned on mid-2025). Dan's ES search cross-check (creatina mujer, café sin nervios, proteína mujer) is the only clean growth read and should run before launch copy locks.
• The clinical-stress tone risk. Part of the stress conversation is genuine mental-health distress; the wrapper must never appear to treat it.
• Creatine fear is the conversion barrier. Bloating, hair-loss and drug-interaction fears are the live objections; the brand wins or loses on reassurance.
• Cohort/format is unresolved by design (§07) — and it changes §08–§09 materially depending on the answer.
• Directional, not precise. Tags are one enrichment pass; life-stage is unknown for ~85%, so the cohort read is directional.

11Roadmap

1. The three of you resolve §07 (cohort × format) using the five questions — that single call unlocks the rest.
2. Dan runs the ES search cross-check; reverse the deck's creatine-out decision.
3. Lock serving size; signed CMO quotes to replace estimated COGS; confirm the coffee-creatine stability the corpus is literally asking about.
4. Survey v2 on the chosen cohort's framing — reassurance language, clarity-and-calm, price tolerance.
5. Resolve the pilates/studio channel (it's also the answer to question 1 in §07).
6. Later: a clean perimenopause read without anchor over-weighting; hair-loss as a candidate fast-follow.